Abstract:Oligodendrocyte progenitor cells (OPCs) play pivotal roles in myelin formation and phagocytosis, communicating with neighboring cells and contributing to the integrity of the blood-brain barrier (BBB). However, under the pathological circumstances of Alzheimer's disease (AD), the brain's microenvironment undergoes detrimental changes that significantly impact OPCs and their functions. Starting with OPC functions, we delve into the transformation of OPCs to myelin-producing oligodendrocytes, the intricate signaling interactions with other cells in the central nervous system (CNS), and the fascinating process of phagocytosis, which influences the function of OPCs and affects CNS homeostasis. Moreover, we discuss the essential role of OPCs in BBB formation and highlight the critical contribution of OPCs in forming CNS-protective barriers. In the context of AD, the deterioration of the local microenvironment in the brain is discussed, mainly focusing on neuroinflammation, oxidative stress, and the accumulation of toxic proteins. The detrimental changes disturb the delicate balance in the brain, impacting the regenerative capacity of OPCs and compromising myelin integrity. Under pathological conditions, OPCs experience significant alterations in migration and proliferation, leading to impaired differentiation and a reduced ability to produce mature oligodendrocytes. Moreover, myelin degeneration and formation become increasingly active in AD, contributing to progressive neurodegeneration. Finally, we summarize the current therapeutic approaches targeting OPCs in AD. Strategies to revitalize OPC senescence, modulate signaling pathways to enhance OPC differentiation, and explore other potential therapeutic avenues are promising in alleviating the impact of AD on OPCs and CNS function. In conclusion, this review highlights the indispensable role of OPCs in CNS function and their involvement in the pathogenesis of AD. The intricate interplay between OPCs and the AD brain microenvironment underscores the complexity of neurodegenerative diseases. Insights from studying OPCs under pathological conditions provide a foundation for innovative therapeutic strategies targeting OPCs and fostering neurodegeneration. Future research will advance our understanding and management of neurodegenerative diseases, ultimately offering hope for effective treatments and improved quality of life for those affected by AD and related disorders.

Cover Image, Volume 72, Issue 4

Cover Image, Volume 71, Issue 5

Cover Image, Volume 72, Issue 3

Cover Image, Volume 532, Issue 2

Cover Image, Volume 528, Issue 6

What Does Cytochrome Oxidase Histochemistry Represent in the Visual Cortex?

Real-Time Characterization of Cell Membrane Disruption by Α-Synuclein Oligomers in Live SH-SY5Y Neuroblastoma Cells.

Volume 97A, Number 9, September 2020 Table of Contents

Cover Image, Volume 39, Issue 2

Back Cover Image, Volume 120, Number 4, April 2023

Many roles for oligodendrocyte precursor cells in physiology and pathology

Back Cover Image

Adult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease

Inside Front Cover Picture: Plasma Process. Polym. 10/2020

Glial Cells in Health and Disease of the CNS

Heterogeneity and Proliferative and Differential Regulators of NG2-glia in Physiological and Pathological States

Cover Image, Volume 62, Issue 7

Identification and two-photon imaging of oligodendrocyte in CA1 region of hippocampal slices.

Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology

Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis

The oligodendrocyte precursor cell in health and disease